Smead Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$31.7M |
| 2 |
GCI
Gannett Co., Inc
GCI
|
+$21.6M |
| 3 |
Gilead Sciences
GILD
|
+$20.2M |
| 4 |
H&R Block
HRB
|
+$17.2M |
| 5 |
NVR
NVR
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLM Corp
SLM
|
+$15.8M |
| 2 |
TGNA
TEGNA Inc
TGNA
|
+$8.38M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$2.94M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$2.71M |
| 5 |
Walt Disney
DIS
|
+$859K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.6% |
| 2 | Healthcare | 25.8% |
| 3 | Consumer Discretionary | 22.79% |
| 4 | Communication Services | 13.26% |
| 5 | Technology | 3.55% |
Similar funds
Smead Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Smead Capital Management held 32 positions worth $1.53B, up 13% from $1.36B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Smead Capital Management deployed $162M of net new capital in Q2 2015, opening 2 new positions and adding to 23 existing holdings. Its largest new stake was American Express: 399,807 shares worth $31.1M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was TEGNA Inc, an estimated $8.38M trimmed.
- Smead Capital Management's largest Q2 2015 buy was American Express: 399,807 shares worth $31.1M.
- Smead Capital Management added most to Gilead Sciences in Q2 2015, an estimated $20.2M increase.
- Smead Capital Management's biggest Q2 2015 reduction was TEGNA Inc, cutting an estimated $8.38M.
- Smead Capital Management fully exited SLM Corp in Q2 2015, selling an estimated $15.8M.
- Smead Capital Management's ten largest holdings make up 50% of its $1.53B portfolio in Q2 2015.
- Smead Capital Management opened 2 new positions and closed 2 in Q2 2015.
- Smead Capital Management's portfolio value rose 13% quarter-over-quarter to $1.53B.
Based on Smead Capital Management's 13F filing for Q2 2015, filed 27 Jul 2015.